LPCN vs XEL · rev $309.5K vs P/E 20, $39.33B cap
Lipocine Inc (LPCN) versus Xcel Energy Inc (XEL) — a side-by-side from cached financials, not a winner call.
Lipocine Inc (LPCN) is a biotechnology company listed on NASDAQ.
Xcel Energy Inc (XEL) is a utilities - regulated electric company listed on US.
Latest reported LPCN revenue for 2026-06-30 was $309.5K. Net income was -$6.3M. LPCN currently screens at market cap $19.3M.
XEL does not have a complete income-statement cache yet.
LPCN currently screens at market cap $19.3M. XEL currently screens at market cap $39.33B and trailing P/E 20.1.
Not investment advice. Open the LPCN and XEL stock pages for the full models.
Not investment advice.